Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Topical tacrolimus reduces certain growth factors in hair follicles.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Ruxolitinib helped a patient with alopecia areata regrow hair.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Intralesional cidofovir may be a viable alternative treatment for SCC.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Isotretinoin treatment increases p53 levels in the skin, which may explain its effectiveness against acne.

Apremilast did not work for treating severe alopecia areata.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.